Cited by 594Estrogen and related hormone effectsAdrenal Hormones and DisordersReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Genomic and nongenomic effects of glucocorticoids

Stahn, Cindy, Buttgereit, Frank·2008·Nature Clinical Practice Rheumatology

Open this paper in CoChat — free account

Abstract

The strong anti-inflammatory and immunosuppressive effects of glucocorticoids are mediated primarily by the cytosolic glucocorticoid receptors. These receptors are members of the steroid hormone receptor family, a superfamily of ligand-inducible transcription factors, and exert genomic effects that can result in increased expression of regulatory-including anti-inflammatory-proteins (transactivation), or decreased production of proinflammatory proteins (transrepression). Transactivation is thought to be responsible for numerous adverse effects of glucocorticoids; transrepression is thought to be responsible for many of the clinically desirable anti-inflammatory and immunosuppressive effects of glucocorticoids. Optimized glucocorticoids, such as selective glucocorticoid receptor agonists, are being developed to try to minimize the adverse effects many patients experience. Glucocorticoids also exert their effects via rapid, nongenomic mechanisms that can be classified as involving nonspecific interactions of glucocorticoids with cellular membranes, nongenomic effects that are mediated by cytosolic glucocorticoid receptors, or specific interactions with membrane-bound glucocorticoid receptors. Increased understanding of these mechanisms of glucocorticoid action could enable the development of novel drugs with which to treat patients with inflammatory and autoimmune disease.

Integrity signals

Registry

Crossref · 10.1038/ncprheum0898

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A. E., Lebo, R. V., Thompson, E. B., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,882
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. C. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.12.1383 · Cited by 699
Basic Guide to the Mechanisms of Antiestrogen Action
MacGregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 698
Steroid hormone receptors: an update
Beato, M. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.3.225 · Cited by 615
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase
Hafezi‐Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J.-C., Rebsamen, M. C., Hsieh, C.-M., Chui, D.-S., Thomas, K. L., Prorock, A. J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-473 · Cited by 596
The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.718 · Cited by 544
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
da Silva, J. A. P., Jacobs, J. W. G., Kirwan, J., Boers, M., Saag, K. G., Inês, L. B. S., de Koning, E. J. P., Buttgereit, F., Cutolo, M., Capell, H., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038638 · Cited by 529
A corticosteroid receptor in neuronal membranes
Orchinik, M., Murray, T. F., & Moore, F. L. (1991) · Science · doi:10.1126/science.2063198 · Cited by 523

Flagged first, then by citations

Show all 65 references

Research works printed but not linked: 1

Bijlsma JW et al. (2007) Systemic and intra-articular glucocorticoids in rheumatoid arthritis. In Rheumatoid arthritis, edn 2, 337–353 (Eds Firestein G. et al.) New York: Oxford University Press

Sorted by citations

Items 301–400 of 592

Update on pharmacology, actions, dosimetry and regimens of oral glucocorticoids in dermatology
Sardana, K., & Sachdeva, S. (2022) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15108 · Cited by 11
Identification of Glucocorticoid Receptor Target Genes That Potentially Inhibit Collagen Synthesis in Human Dermal Fibroblasts
Choi, D., Kang, W., Park, S., Son, B., & Park, T. (2023) · Biomolecules · doi:10.3390/biom13060978 · Cited by 13
Progress on diagnosis and treatment of multisystem inflammatory syndrome in children
Peng, Z., & Zhou, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551122 · Cited by 14
“Their non-genomic effects on both immune and endothelial cells involve modulation of membrane permeability and T-cell signaling (72, 73).”
Systemic glucocorticoids in rheumatology
Saag, K. G., & Buttgereit, F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00054-1 · Cited by 12
Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis
Libánská, A., Randárová, E., Skoroplyas, S., Bartoš, M., Luňáčková, J., Lager, F., Renault, G., Scherman, D., & Etrych, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.027 · Cited by 12
Loteprednol Etabonate Ophthalmic Gel 0.5% Following Cataract Surgery: Integrated Analysis of Two Clinical Studies
Rajpal, R. K., Fong, R., & Comstock, T. L. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0059-7 · Cited by 12
“It also has a higher binding affinity for rat lung type II glucocorticoid receptors compared with dexamethasone [19], and a therapeutic index more than 20-fold higher than other corticosteroids [20].”
Background
Prednisolone and vitamin D(3) modulate oxidative metabolism and cell death pathways in blood and bone marrow mononuclear cells
Shymanskyi, I., Lisakovska, O., Mazanova, A., Labudzynskyi, D. О., Khomenko, A., & Veliky, M. M. (2016) · The Ukrainian Biochemical Journal · doi:10.15407/ubj88.05.038 · Cited by 12
Glucococorticoid-Induced Death of Pancreatic Beta Cells: An Organized Chaos
Rojas, J., Chávez-Castillo, M., Chávez-Castillo, M., Cabrera, M., Cabrera, M., Bermúdez, V., & Bermúdez, V. (2015) · PubMed · doi:10.6092/1590-8577/2893 · Cited by 12
“Much like other steroid hormones, GC act mainly through genetic induction and/or repression [14], and although novel non-genomic mechanisms have recently been described [15], these have not yet been described to be related to cell survival/death.”
Background
Intra-articular glucocorticoid injections decrease the number of steroid hormone receptor positive cells in synovial tissue of patients with persistent knee arthritis
van der Goes, M. C., Straub, R. H., Wenting, M. J. G., Capellino, S., Jacobs, J. W. G., Jahangier, Z. N., Rauch, L., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201019 · Cited by 12
Polymorphic variants of MIF gene and prognosis in steroid therapy in children with idiopathic nephrotic syndrome.
Świerczewska, M., Ostalska‐Nowicka, D., Kempisty, B., Szczepankiewicz, A., & Nowicki, M. O. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1925 · Cited by 12
“Nongenomic mechanisms include interactions of GCs with cell membrane, cytosolic GR and with cell membrane-bound GR (Smoak & Cidlowski, 2004; Stahn & Buttgereit, 2008; Alangari, 2010).”
Background
Intra-articular glucocorticoids for acute gout
Wechalekar, M. D., Vinik, O., Schlesinger, N., & Buchbinder, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009920 · Cited by 12
Deep Neck Infection in Systemic Lupus Erythematosus Patients: Real-World Evidence
Chang, G., Su, Y., Lin, K., Liu, C., Yang, Y., Chang, P., Lin, M., Lee, C.-P., Hsu, C., Tsai, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61049-4 · Cited by 11
Methylprednisolone pulse therapy promotes the differentiation of regulatory T cells by inducing the apoptosis of CD4+ T cells in patients with systemic lupus erythematosus
Sun, J., Lyu, T., Chen, Z., Lian, C., Liu, S., Shao, T.-H., Zhang, S., Zhao, L., Liu, J.-J., Peng, L., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109079 · Cited by 11
Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
Zielińska, K. A., Cauwer, L. D., Knoops, S., der Molen, K. V., Sneyers, A., Thommis, J., de Souza, J. B., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01199 · Cited by 11
“GCs exert their antiinflammatory and immunosuppressive effects mainly via the glucocorticoid receptor (GR) which belongs to the superfamily of ligand-inducible transcription factors (17).”
Background
Glucocorticoids and serum- and glucocorticoid-inducible kinase 1 are potent regulators of CFTR in the native intestine: implications for stress-induced diarrhea
Ahsan, M. K., Figueroa‐Hall, L. K., Baratta, V. M., García-Milian, R., Lam, T. T., Hoque, K. M., Salas, P. J. I., & Ameen, N. A. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2020 · Cited by 12
“In contrast, nongenomic regulation involves rapid cellular changes resulting from specific interactions with membrane-associated proteins and receptors and the release of proteins from the cGCR complex (16, 46) that does not involve modulation of gene expression.”
Background
Prednisolone increases neural reactivity to negative socio-emotional stimuli in healthy young men
Buades‐Rotger, M., Serfling, G., Harbeck, B., Brabant, G. E., & Krämer, U. M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.04.010 · Cited by 10
“…E20-fold increase in median serum cortisol concentrations around 35 min after injection (Niedermeyer et al., 2003), and can be safely assumed to later produce a prototypical endogenous cortisol suppression through GR saturation (Czock et al., 2005; Russell et al., 2010; Stahn and Buttgereit, 2008).”
Background
Review of glucocorticoid therapy in horses: Intra‐articular corticosteroids
Boorman, S., McMaster, M. A., Groover, E. S., & Caldwell, F. J. (2022) · Equine Veterinary Education · doi:10.1111/eve.13719 · Cited by 10
Inflammatory response after prehospital high-dose glucocorticoid to patients resuscitated from out-of-hospital cardiac arrest: A sub-study of the STEROHCA trial
Obling, L. E. R., Beske, R. P., Meyer, M., Grand, J., Wiberg, S. C., Damm-Hejmdal, A., Bjerre, M., Frikke‐Schmidt, R., Folke, F., Møller, J. E., et al. (2024) · Resuscitation · doi:10.1016/j.resuscitation.2024.110340 · Cited by 10
Comparison of Cellular and Transcriptional Responses to 1,25-Dihydroxyvitamin D3 and Glucocorticoids in Peripheral Blood Mononuclear Cells
Kupfer, S. S., Maranville, J., Baxter, S. S., Huang, Y., & Rienzo, A. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076643 · Cited by 10
The expression of selected genes linked to metabolic homeostasis in obese pansteatitis‐suffering M ozambique tilapia, O reochromis mossambicus ( P eters)
Truter, J. C., van Wyk, J. H., Oberholster, P. J., Botha, A., & Luus-Powell, W. J. (2014) · Journal of Fish Diseases · doi:10.1111/jfd.12324 · Cited by 10
Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism
Ni, J., Li, J., Wang, Y., Guan, L., Lin, H., Zhang, L., & Zhang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.920283 · Cited by 10
“One is the genomic way that includes two different processes, namely transactivation and transrepression (24), ultimately lowering the expression of proinflammatory cytokines such as TNF-a, IL-8, IL-6 or increasing the expression of anti-inflammatory proteins such as IL-10.”
Background
Treatment of multisystem inflammatory syndrome in children
Tong, T., Jin, Y.-H., Wang, M., & Gong, F. (2024) · World Journal of Pediatrics · doi:10.1007/s12519-024-00798-y · Cited by 12
“…that play a role by enacting the nuclear transrepression of proinflammatory genes to inhibit the production of cytokines as well as through nongenomic effects on immune and endothelial cells, including membrane permeability, adenosine triphosphate production, and T-cell receptor signaling [41, 42].”
Elevated oxytocin and noradrenaline indicate higher stress levels in allergic rhinitis patients: Implications for the skin prick diagnosis in a pilot study
Gotovina, J., Pranger, C. L., Jensen, A. N., Wagner, S., Kothgassner, O. D., Mothes‐Luksch, N., Palme, R., Larenas‐Linnemann, D. E., Singh, J., Mösges, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196879 · Cited by 10
Corticosteroid Tapering Regimens in Rheumatic Disease
Campbell, A., Martin, J. R., & Erstad, B. L. (2018) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000917 · Cited by 10
Acute stress induces visceral hypersensitivity via glucocorticoid receptor–mediated membrane insertion of TRPM8: Involvement of a non‐receptor tyrosine kinase Pyk2
Luo, Q., Wang, B., Chen, X., Qiu, H.-Y., Li, W., Yan, X., & Chen, S. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13877 · Cited by 10
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
Obling, L. E. R., Beske, R. P., Wiberg, S. C., Folke, F., Moeller, J. E., Kjærgaard, J., & Hassager, C. (2022) · Trials · doi:10.1186/s13063-022-06838-0 · Cited by 10
“These anti-inflammatory effects are mediated through a slow genomic response (hours) and a rapid non-genomic response (seconds/minutes) [23].”
Background
Effects of dexamethasone on purinergic signaling in murine mast cells: Selective suppression of P2X7 receptor expression
Yoshida, K., Ito, M., Hoshino, Y., & Matsuoka, I. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.020 · Cited by 10
Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis
Gatto, M., Frontini, G., Furlan, C., Calatroni, M., Cruciani, C., Reggiani, F., Bellis, E., Iaccarino, L., Sinico, R. A., Moroni, G. L., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.02.004 · Cited by 9
Long-term efficacy and safety of the Lupus-Cruces Nephritis protocol: a propensity score study of the Lupus-Cruces and Lupus-Bordeaux cohorts
Ruiz‐Irastorza, G., Marín-García, B., Dueña-Bartolomé, L., Paredes, D., Osorio, A., & Lazaro, E. (2025) · Lupus Science & Medicine · doi:10.1136/lupus-2025-001562 · Cited by 9
Severe community-acquired pneumonia: an integral approach
Asis, A., McMahon, D., Fujitani, S., Póvoa, P. M. S. R., Rodriguez, A., Reyes, L. F., & Martín‐Loeches, I. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00854-x · Cited by 10
“Corticosteroids have long been considered an adjunctive strategy in severe community–acquired pneumonia, aiming to suppress excessive inflammation, preserve endothelial integrity, and enhance cardiovascular stability [67–69].”
Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents
Yu, J., Park, M., & Jo, S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.007 · Cited by 9
Differential distribution of steroid hormone signaling networks in the human choroid-retinal pigment epithelial complex
Galindez, S. M., Keightley, A., & Koulen, P. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02585-7 · Cited by 9
“GC can suppress the transcription of VEGF, which has been demonstrated to be secreted and produced by RPE cells, astrocytes, MG, vascular endothelium, and ganglion cells [19, 24].”
BackgroundInfluential
Documento de consenso del Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) para el diagnóstico y tratamiento de la nefritis lúpica
Rojas-Rivera, J. E., García-Carro, C., Ávila, A. I., Espino, M., Espinosa, M., Juarez, G. M. F., Fulladosa, X., Goicoechea, M., Macia, M. L., Morales, E., et al. (2022) · Nefrología · doi:10.1016/j.nefro.2022.10.005 · Cited by 10
“La CYC oral es un régimen efectivo para alcanzar RC a corto y largo plazo, incluso comparado con micofenolato, pero aumenta el riesgo de efectos adversos dado que supone tres veces más dosis acumulada de CYC que los regímenes intravenosos 49 .”
The effect of acute and short term glucocorticoid administration on exercise capacity and metabolism
Tacey, A., Parker, L., GARNHAM, A. P., Brennan‐Speranza, T. C., & Levinger, I. (2017) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2016.10.016 · Cited by 9
The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome
Katz, A., Altshuler, D., Papadopoulos, J., Amoroso, N. E., Goldenberg, R., Tarras, E. S., Krolikowski, K., Hagedorn, J., Fridman, D., Chen, X. J. C., et al. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221094571 · Cited by 9
“05 Duration of mechanical ventilation, (days) 14 (8-30) 10 (4-29) 0.”
Influential
Perspectives on the use of non-biological pharmacotherapy for adult-onset Still’s disease
Cola, I. D., Cipriani, P., & Ruscitti, P. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2126764 · Cited by 9
“In addition, the effectiveness of 12 months therapy with tocilizumab, a monoclonal antibody against IL-6 receptor, was assessed in 11 patients with AOSD refractory to GCs and MTX [60].”
BackgroundInfluential
Hyperinsulinemia during oral glucose tolerance test and high normal serum cortisol are associated with increased secretion of calcitonin in normal subjects
Polymeris, A., Papapetrou, P. D., Papandroulaki, F., & Thanou, S. (2011) · HORMONES · doi:10.14310/horm.2002.1322 · Cited by 9
“Serum calcitonin was measured by chemiluminescence - Nichols Advantage calcitonin immunoassay which detects mainly the CT (1-32) monomer(5) with a functional sensitivity 2 pg/ml.”
Method
Systemic use of non‐biologic corticosteroids in orofacial diseases
Georgakopoulou, E. A., & Scully, C. M. (2013) · Oral Diseases · doi:10.1111/odi.12132 · Cited by 9
Signaling Cascade Involved in Rapid Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Dexamethasone
Bossmann, M., Ackermann, B., Thome, U. H., & Laube, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081807 · Cited by 9
“In addition, rapid GC effects can be mediated by nonspecific interactions of GCs with cellular membranes and specific interactions with membrane-bound GRs [3].”
BackgroundInfluential
Remodeling of Zn2+ homeostasis upon differentiation of mammary epithelial cells
Han, Y., Sanford, L., Simpson, D. M., Dowell, R. D., & Palmer, A. E. (2020) · Metallomics · doi:10.1039/c9mt00301k · Cited by 9
Transcript- and protein-level analyses of the response of human eosinophils to glucocorticoids
Gadkari, M., Makiya, M. A., Legrand, F., Stokes, K., Brown, T., Howe, K. N., Khoury, P., Hu, Z., Klion, A. D., & Franco, L. M. (2018) · Scientific Data · doi:10.1038/sdata.2018.275 · Cited by 11
Early Treatment of Multisystem Inflammatory Syndrome in Children
Jonat, B., Geneslaw, A. S., Capone, C. A., Shah, S. S., Bartucca, L., Sewell, T. B., Acker, K. P., Mitchell, E., & Cheung, E. W. (2023) · PEDIATRICS · doi:10.1542/peds.2023-061297 · Cited by 8
Dexamethasone release pattern via a three-dimensional system for effective bone regeneration
Channey, H. S., Holkar, K., Kale, V. P., & Ingavle, G. C. (2023) · Biomedical Materials · doi:10.1088/1748-605x/acdb1e · Cited by 8
“The side effects depend upon the current and accumulated dosages [61, 62].”
Glucocorticoid-Induced Osteoporosis (GIOP)
Jha, S. S. (2023) · Indian Journal of Orthopaedics · doi:10.1007/s43465-023-01037-8 · Cited by 8
Methylprednisolone prevents tumour necrosis factor- -dependent multinucleated giant cell formation
Maltesen, H. R., Nielsen, C. H., Eickhardt‐Dalbøge, C. S., & Baslund, B. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq213 · Cited by 8
Transforming growth factor‐β‐activated kinase 1 resistance limits glucocorticoid responsiveness to Toll‐like receptor 4‐mediated inflammation
Kong, F., Laryea, G. N., Liu, Z., & Bhattacharyya, S. (2014) · Immunology · doi:10.1111/imm.12434 · Cited by 8
Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility
Cromarty, R. T., & Archary, D. (2020) · AIDS Research and Treatment · doi:10.1155/2020/8672850 · Cited by 8
“GCsmodulate immunity through the interference of gene transcription, resulting in impaired signalling pathways [183, 184], and through nongenomic effects such as interactions with cellular membranes and receptors to initiate or inhibit signalling responses [185].”
Background
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma
Ghiciuc, C. M., Vicovan, A. G., Stafie, C. S., Antoniu, S. A., & Postolache, P. A. (2021) · Marine Drugs · doi:10.3390/md19110586 · Cited by 8
Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides—Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort
Palmowski, A., Wiebe, E., Muche, B., Hermann, S., Dejaco, C., Matteson, E. L., & Buttgereit, F. (2022) · Cells · doi:10.3390/cells11030536 · Cited by 8
“They have unparalleled anti-inflammatory and immunomodulatory effects, mediated by both genomic and non-genomic modes of action [7].”
Background
State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis
Pelechas, E., & Drosos, A. A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2049238 · Cited by 8
“A “pulse” is considered between 250 and 1000 mg/day for 1–3 days [12].”
Background
Steroids for LBP – from rationale to inconvenient truth
Balagué, F., Piguet, V., & Dudler, J. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13566 · Cited by 8
Wound-healing and benzodiazepines: does sleep play a role in this relationship?
Egydio, F., Pires, G. N., Tufik, S. B., & Andersen, M. L. (2012) · Clinics · doi:10.6061/clinics/2012(07)20 · Cited by 8
“Specifically, dermatologic lesions can trigger psychological alterations such as stress (10), and stressful situations may trigger alterations in the immune system as a consequence of the activation of the hypothalamic-pituitary adrenal axis (HPA) and increased glucocorticoids (11; see (16) for review), which may then…”
Background
Methylprednisolone as a memory enhancer in rats: Effects on aversive memory, long-term potentiation and calcium influx
de Vargas, L. D. S., Gonçalves, R., de Lara, M. V. S., Costa‐Ferro, Z. S. M., Salamoni, S. D., Domingues, M. F., Piovesan, A. R., de Assis, D. R., Vinadé, L., Corrado, A. P., et al. (2017) · Brain Research · doi:10.1016/j.brainres.2017.06.007 · Cited by 8
Arthritic Conditions Affecting the Temporomandibular Joint
Mercuri, L. G., & Abramowicz, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-28100-1_32-1 · Cited by 8
“Glucocorticoids act through the cytosolic steroid hormone receptor, resulting in increased expression of anti-inflammatory proteins and decreased production of proinflammatory proteins (Stahn and Buttgereit 2008).”
Background
Corticosteroids
Lim, S. Y., & Bolster, M. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-16928-2_28 · Cited by 8
RNA-Seq Bayesian Network Exploration of Immune System in Bovine
Behdani, E., Ghaderi‐Zefrehei, M., Rafeie, F., Bakhtiarizadeh, M. R., Roshanfekr, H., & Fayazi, J. (2019) · Iranian Journal of Biotechnology · doi:10.29252/ijb.1748 · Cited by 7
“In addition, TERF2IP controls apoptosis through NF-κB led to regulating immune responses and preventing development of immune functions (32).”
Background
Activation of glucocorticoid receptors is associated with the suppression of antioxidant responses in the liver of goats fed a high-concentrate diet
Wang, Y., Salem, A. Z. M., Tan, Z., Kang, J., & Wang, Z. (2021) · Italian Journal of Animal Science · doi:10.1080/1828051x.2021.1873706 · Cited by 7
“GC increases in response to stress via the hypothalamic–pituitary–adrenal (HPA) axis, influencing the intracellular glucocorticoid receptor (GR) and modulating the expression of different target genes (stressresponse genes) (Prunet et al. 2006; Stahn and Buttgereit 2008; Ayroldi et al. 2012).”
Background
IGA nephropathy – Are intravenous steroid pulses more effective than oral steroids in relapse prevention?
Laranjinha, I., Matias, P., Cassis, J., Branco, P. Q., Ramos, S., Barata, J. D., & Weigert, A. L. L. (2017) · Nefrología · doi:10.1016/j.nefro.2017.08.004 · Cited by 7
Application of ELISA Technique and Human Microsomes in the Search for 11β-Hydroxysteroid Dehydrogenase Inhibitors
Kupczyk, D., Studzińska, R., Bilski, R., & Woźniak, A. (2019) · BioMed Research International · doi:10.1155/2019/5747436 · Cited by 7
“Through the process of integration into the cellular and mitochondrial membranes, changes in the function of membrane proteins may occur and thus affect their permeability and enhance the processes of lipid peroxidation [17].”
Background
Stress and Reproduction in Amphibians
Carr, J. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374932-1.00019-6 · Cited by 7
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus
Yusof, M. Y. M., Smith, E. M. D., Lythgoe, H., Psarras, A., Armon, K., Beresford, M. W., Cherry, L. S., Edwards, C. J., Felix, L., Flora, K., et al. (2026) · Rheumatology · doi:10.1093/rheumatology/keag223 · Cited by 10
Exploring Microemulsion Systems for the Incorporation of Glucocorticoids into Bacterial Cellulose: A Novel Approach for Anti-Inflammatory Wound Dressings
Zahel, P., Bruggink, V., Hülsmann, J., Steiniger, F., Hofstetter, R. K., Heinzel, T., Beekmann, U., Werz, O., & Kralisch, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040504 · Cited by 6
“…transcription factors, such as NF κ B and activating protein-1 (AP-1) through direct and indirect interactions, preventing their DNA binding and therefore suppressing the synthesis of pro-inflammatory cytokines, e.g., IL-1, IL-2, IL-6, tumor necrosis factor α (TNF α ) and interferon γ [3,7,8].”
BackgroundInfluential
Engineered Nanomicelles Delivering the Combination of Steroids and Antioxidants Can Mitigate Local and Systemic Inflammation, Including Sepsis
Rana, K., Yadav, P., Chakraborty, R., Jha, S. K., Agrawal, U., & Bajaj, A. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c14159 · Cited by 6
The Shifting Landscape of Lupus Nephritis Management: A Review
Bankole, A. A., & Nwaonu, J. (2022) · Cureus · doi:10.7759/cureus.20950 · Cited by 6
“The mechanisms of action of GC are now better understood as genomic mechanisms involving receptor binding, translocation to the nucleus, and binding to DNA binding sites known collectively as glucocorticoid response elements [45], and non-genomic mechanisms of action via the inactivation of the phospholipase A2 enzyme…”
Background
Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study
Klahn, S. L., Dervisis, N. G., Lahmers, K. K., & Benitez, M. (2022) · Veterinary Sciences · doi:10.3390/vetsci9060277 · Cited by 6
“Intracellular signaling is altered due to the release of proteins from the cGCR multi-protein complex upon the binding of glucocorticoids, resulting in rapid anti-inflammatory effects [56].”
BackgroundInfluential
Early transcriptomic response of mouse adrenal gland and Y-1 cells to dexamethasone
Zheng, H. S., Daniel, J. G., Salamat, J. M., Mackay, L., Foradori, C. D., Kemppainen, R. J., Pondugula, S. R., Tao, Y., & Huang, C. J. (2022) · Endocrine Connections · doi:10.1530/ec-22-0064 · Cited by 5
Non-genomic action of beclomethasone dipropionate on bronchoconstriction caused by leukotriene C4 in precision cut lung slices in the horse
Fugazzola, M. C., Barton, A. K., Niedorf, F., Kietzmann, M., & Ohnesorge, B. (2012) · BMC Veterinary Research · doi:10.1186/1746-6148-8-160 · Cited by 6
Voie de signalisation Sonic Hedgehog et impact des glucocorticoïdes sur le cerveau en développement
Baud, O., & Gressèns, P. (2009) · médecine/sciences · doi:10.1051/medsci/2009258-9713 · Cited by 6
Anti-oxidant and Anti-inflammatory Activities of Manilkara zapota (Sapodilla) In vitro and Efficiency in Healthy Elderly Persons
Leelarungrayub, J. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.15.002684 · Cited by 6
“These results showed a significant depression of TNF-α releases after 24 h incubation, which is the same for hydrocortisone that is an important glucocorticoid and has anti-inflammatory and immunosuppressive properties [57].”
Background
Oxidative Stress in Experimental Models of Acute Lung Injury
Mokrá, D., & Mokrý, J. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_2 · Cited by 6
Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate
Berger, M., May, E., Rehwinkel, H., Schäcke, H., Neuhaus, R., Rottmann, A., Zollner, T. M., & Jaroch, S. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127298 · Cited by 6
Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation
Jannuzzi, A. T., Korkmaz, N. S., Akyıldız, A. G., Arslan-Eseryel, S., Karademir-Yilmaz, B., & Alpertunga, B. (2023) · Cardiovascular Toxicology · doi:10.1007/s12012-023-09785-7 · Cited by 6
“Due to their anti-inflammatory and immunosuppressive effects, glucocorticoids are successfully in therapeutic use for various conditions [34].”
Background
Synthetic pharmacotherapy for lupus nephritis
Moroni, G. L., & Ponticelli, C. E. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1276563 · Cited by 6
“Here, GRs bind to specific glucocorticoid response elements, which regulate the transcription of anti-inflammatory genes.”
BackgroundInfluential
Con: Corticosteroids Are Useful in the Management of HAPE
Mairbäurl, H., & Baloğlu, E. (2015) · High Altitude Medicine & Biology · doi:10.1089/ham.2015.0071 · Cited by 6
“Most of their effects are mediated by widely distributed cytosolic receptors belonging to the steroid, thyroid, retinoic acid superfamily of nuclear receptors (Stahn and Buttgereit, 2008).”
Early clinical outcomes following laparoscopic inguinal hernia repair.
Tolver, M. A. (2013) · PubMed · Cited by 6
Association between glucocorticoid use and all-cause mortality in critically ill patients with heart failure: A cohort study based on the MIMIC-III database
Zhu, J.-L., Liang, H., Yuan, S., Xu, X.-M., Wei, J., & Yin, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1118551 · Cited by 5
Stress and reproduction in amphibians
Carr, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16020-2.00002-4 · Cited by 5
Examination of the effects of short-term oxidative stress on glucocorticoid conversion in marine mussels
Hallmann, A., Chomiczewska, A., Goździk, P., Leszczyńska, D., & Smolarz, K. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742150 · Cited by 5
The effects of stress on working-memory-related prefrontal processing: an fNIRS study
Geissler, C. F., Frings, C., & Domes, G. (2025) · Stress · doi:10.1080/10253890.2025.2472067 · Cited by 5
“…(Droste et al., 2008). the glucocorticoid effects on central processing can be categorized into rapid (non-genomic) effects that unfold within a timeframe of several minutes post stress and slow (genomic) effects that unfold in a timeframe of hours to days after stress (stahn & Buttgereit, 2008).”
Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
Ovejero, S., & Moreaux, J. (2021) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2021.00034 · Cited by 5
“Once in the nucleus, they bind the GC response elements to regulate gene expression, either activating (Annexin I, MAPK) or inhibiting it (NF-κB, AP-1) [72, 73].”
Background
Bioactive Compounds from Herbal Medicine Targeting Multiple Myeloma
Cotoraci, C. A., Ciceu, A., Sasu, A., Miuţescu, E., & Hermenean, A. O. (2021) · Applied Sciences · doi:10.3390/app11104451 · Cited by 7
Immunoglobulin G inhibits glucocorticoid-induced osteoporosis through occupation of FcγRI
Jiang, L., Qiu, W., Wang, X., Duan, X., Han, X., Yu, T., Wen, S., Luo, Z., Feng, R., Teng, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107749 · Cited by 5
“GCs potently regulate gene expression through glucocorticoid receptors (GRs), including cytosolic GR (cGR) (majority)(1,2) andmembrane-boundGR (mGR).(3) However, glucocorticoid-induced osteoporosis (GIOP) is themost common formof secondary osteoporosis and represents a significant concern in patients on long-term trea…”
Background
Black pepper (Piper nigrum L.) essential oil counteracts dexamethasone-induced hepatic injury via modulating PGC-1α/ PPAR-α pathway in rats
Mahmoud, M. F., Mahdi, I., Ali, N., Dib, H., El-Shazly, A. M., Mostafa, I., Abdelfattah, M. A. O., Hasan, R. A., & Sobeh, M. (2024) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2024.105690 · Cited by 5
Steroids and Immunomodulatory Therapies for Acute Respiratory Distress Syndrome
Millar, J. E., Craven, T., & Shankar‐Hari, M. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.08.011 · Cited by 5
Determination of oxidative stress and copeptin levels of COVID-19 according to the clinical course
Abdelmageed, M., Güzelgül, F., Yalın, S., & AKKAPULU, M. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107263 · Cited by 5
Prinzipien der Steroidtherapie
Ehrchen, J. M. (2012) · Der Hautarzt · doi:10.1007/s00105-012-2471-3 · Cited by 5
Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia
Mastruzzo, C., Commodari, E., Grasso, U., Rosa, V. L. L., Balsamo, D., Circo, C., & Oliveri, R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021081 · Cited by 5
“Corticosteroid pulses have been suggested to show higher clinical benefits than low-dose corticosteroids because they act on different pathways that perform genomic and non-genomic functions [18,19] with the expectation of strong suppression of the cytokine storm that prevents the organization of pneumonia and lung fi…”
Background
Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review
Andaluz‐Ojeda, D., Vidal, P., Sanz, Á. A., Suberviola, B., Carbajo, L. D. R., Martín, L. N., Silva, E. P., Olmo, J. N.-D., Barberán, J., & Cusácovich, I. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i4.269 · Cited by 6
Inhalable dexamethasone-loaded zwitterionic nanomicelles enabling effective penetration of the mucus barrier for acute lung injury treatment
Chen, R., Dai, X., Sun, R., Liao, Y., Dong, J., Tan, Y. C., & Jin, X. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166117 · Cited by 4
The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care
Ciurtin, C., Spârchez, M., Eleftheriou, D., & Brogan, P. A. (2025) · Lara D. Veeken · doi:10.1093/rheumatology/keaf455 · Cited by 4
Ways to improve the effectiveness of glaucoma filtering surgery
Nikolaenko, V. P., Аntonova, А. V., & Brzhesky, V. V. (2024) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2024-17-2-99-107 · Cited by 4
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas
Bhatt, B., & Franco, L. M. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101949 · Cited by 5
Логіка глюкокортикоїдної терапії
Khodosh, E. M., Nartov, P., Yakovenkо, O. К., Asoyan, I. M., & Sirota, V. V. (2023) · Asthma and allergy · doi:10.31655/2307-3373-2023-1-63-71 · Cited by 6
Development and validation of a nomogram for predicting pulmonary infection in patients receiving immunosuppressive drugs
Luo, C., Zhang, Y., Zhang, J., Jin, C., Ye, X., Ren, Y., Shen, H., Chen, M., Li, Y., He, Q., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1255609 · Cited by 4
Knockout in zebrafish reveals the role of the glucocorticoid receptor in shaping behavioral syndromes
Rovegno, E., Lucon‐Xiccato, T., Terrin, F., Valle, L. D., & Bertolucci, C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115179 · Cited by 4
“Besides the non-genomic effects that GCs mainly exert through the interaction with cytosolic or membrane-bound receptors [88], GCs can also cross cell membranes and regulate transcription of target genes upon the activation of two different intracellular steroid receptors: mineralocorticoid…”
Background
Expression of glucocorticoid-receptor covaries with individual differences in visual lateralisation in zebrafish
Rovegno, E., Frigato, E., Valle, L. D., Bertolucci, C., & Lucon‐Xiccato, T. (2025) · Animal Cognition · doi:10.1007/s10071-025-01943-4 · Cited by 4
“GCs act through both non-genomic mechanisms, such as interactions with mem - brane-bound receptors, and genomic pathways (Stahn and Buttgereit 2008 ).”
Neoplastic/Pathological and Nonneoplastic/Physiological Hypercortisolism: Cushing Versus Pseudo-Cushing Syndromes
Findling, J. W., & Raff, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_6 · Cited by 4
Glucocorticoid susceptibility and in vivo ABCB1 activity differ in murine B cell subsets
da Costa, K. M., Valente, R. D. C., SILVA, J. M. C. D., de Paiva, L. S., & Rumjanek, V. M. (2018) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201820180364 · Cited by 4
“Nongenomic signaling pathway appears to be mediated by glucocorticoid interactions either with cell membranes, with cytoplasmic or membrane-bound GR (Stahn and Buttgereit 2008).”
Background
Long term effects of corticosteroids in multiple sclerosis in terms of the “no evidence of disease activity” (NEDA) domains
Saied, A., Elsaid, N. A., & Azab, A. (2019) · Steroids · doi:10.1016/j.steroids.2019.04.006 · Cited by 4
Corticosterone in the ventral hippocampus differentially alters accumbal dopamine output in drug-naïve and amphetamine-withdrawn rats
Bray, B., Clement, K. A., Bachmeier, D., Weber, M. A., & Forster, G. L. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107924 · Cited by 4
“Typically, steroid effects within 30 minutes of onset are associated with non-genomic mechanisms (Barr et al., 2017; de Kloet et al., 2008; Groeneweg et al., 2012; Haller et al., 2008; Makara and Haller, 2001; Prager and Johnson, 2009; Stahn and Buttgereit, 2008; Stahn et al., 2007).”
Background

Authors: Stahn, C., & Buttgereit, F.
Affiliations: Charité – Universitätsmedizin Berlin (DE)
Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
Corresponding author: Buttgereit, Frank
ORCID: Buttgereit, Frank
Venue: Nature Clinical Practice Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2008-09-02
Volume: 4
Issue: 10
Pages: 525-533
ISSN: 1745-8382 (ISSN-L)
1745-8390
DOI: 10.1038/ncprheum0898
OpenAlex: W1968436319
Cited by: 594
References: 65
Citations by year: 2026: 19 · 2025: 26 · 2024: 29 · 2023: 40 · 2022: 49 · 2021: 33 · 2020: 46 · 2019: 40 · 2018: 26 · 2017: 35 · 2016: 27 · 2015: 37 · 2014: 41 · 2013: 31 · 2012: 29
FWCI: 2.66
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Clinical Practice Rheumatology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: glucocorticoids, glucocorticoid receptor, genomic mechanisms, transcriptional activation, transrepression, steroid hormone receptors, selective glucocorticoid receptor agonists, adverse effects, anti-inflammatory activity, immunosuppression, rheumatic diseases
MeSH terms: Anti-Inflammatory Agents, Cell Membrane, Dose-Response Relationship, Drug, Glucocorticoids, Humans, Immunosuppressive Agents, Ligands, Receptors, Glucocorticoid, Rheumatology, Transcriptional Activation, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genomic and nongenomic effects of glucocorticoids

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks